Geva R - Search Results

1

Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.

Barenboim A, Lahat G, Geva R, Nachmany I, Nakache R, Goykhman Y, Brazowski E, Rosen G, Isakov O, Wolf I, Klausner JM, Lubezky N. Barenboim A, et al. Among authors: geva r. Eur J Surg Oncol. 2018 Oct;44(10):1619-1623. doi: 10.1016/j.ejso.2018.07.057. Epub 2018 Aug 2. Eur J Surg Oncol. 2018. PMID: 30146251

2

Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?

Tulchinsky H, Rabau M, Shacham-Shemueli E, Goldman G, Geva R, Inbar M, Klausner JM, Figer A. Tulchinsky H, et al. Among authors: geva r. Ann Surg Oncol. 2006 Mar;13(3):347-52. doi: 10.1245/ASO.2006.03.029. Epub 2006 Feb 1. Ann Surg Oncol. 2006. PMID: 16450221

3

The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.

Lubezky N, Metser U, Geva R, Nakache R, Shmueli E, Klausner JM, Even-Sapir E, Figer A, Ben-Haim M. Lubezky N, et al. Among authors: geva r. J Gastrointest Surg. 2007 Apr;11(4):472-8. doi: 10.1007/s11605-006-0032-8. J Gastrointest Surg. 2007. PMID: 17436132 Free PMC article.

4

Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?

Lubezky N, Geva R, Shmueli E, Nakache R, Klausner JM, Figer A, Ben-Haim M. Lubezky N, et al. Among authors: geva r. World J Surg. 2009 May;33(5):1028-34. doi: 10.1007/s00268-009-9945-1. World J Surg. 2009. PMID: 19234865

5

Perioperative complications after neoadjuvant chemotherapy with and without bevacizumab for colorectal liver metastases.

Lubezky N, Winograd E, Papoulas M, Lahat G, Shacham-Shmueli E, Geva R, Nakache R, Klausner J, Ben-Haim M. Lubezky N, et al. Among authors: geva r. J Gastrointest Surg. 2013 Mar;17(3):527-32. doi: 10.1007/s11605-012-2108-y. Epub 2013 Jan 9. J Gastrointest Surg. 2013. PMID: 23299220

6

Should a loop ileostomy closure in rectal cancer patients be done during or after adjuvant chemotherapy?

Tulchinsky H, Shacham-Shmueli E, Klausner JM, Inbar M, Geva R. Tulchinsky H, et al. Among authors: geva r. J Surg Oncol. 2014 Mar;109(3):266-9. doi: 10.1002/jso.23493. Epub 2013 Nov 19. J Surg Oncol. 2014. PMID: 24249401

7

Is there a role for adjuvant chemotherapy in pathological complete response rectal cancer tumors following neoadjuvant chemoradiotherapy?

Geva R, Itzkovich E, Shamai S, Shacham-Shmueli E, Soyfer V, Klausner JM, Tulchinsky H. Geva R, et al. J Cancer Res Clin Oncol. 2014 Sep;140(9):1489-94. doi: 10.1007/s00432-014-1712-5. Epub 2014 May 22. J Cancer Res Clin Oncol. 2014. PMID: 24849731

8

PANCREATIC INCIDENTALOMA: DIFFERENTIATING NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS FROM INTRAPANCREATIC ACCESSORY SPLEEN.

Osher E, Scapa E, Klausner J, Greenman Y, Tordjman K, Melhem A, Nachmany I, Sofer Y, Geva R, Blachar A, Stern N, Santo E. Osher E, et al. Among authors: geva r. Endocr Pract. 2016 Jul;22(7):773-9. doi: 10.4158/EP151091.OR. Epub 2016 Feb 26. Endocr Pract. 2016. PMID: 26919653

9

Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?

Geva R, Davidovics H, Soyfer S, Pelles-Avraham S, Klausner JM, Inbar M, Tulchinsky H. Geva R, et al. Colorectal Dis. 2017 Mar;19(3):237-242. doi: 10.1111/codi.13474. Colorectal Dis. 2017. PMID: 27474791

10

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page